Multiple studies have shown that GLUT1 exhibits a high expression trend in the development of various tumours (oesophageal cancer, prostate cancer, lung cancer) and can affect tumour progression by mediating glycolysis, tumour cell proliferation, and immune cell infiltration [14], [15], [16]. The gene discussed is SLC2A1; the disease is neoplasm.